Board Meeting4 Nov 2026, 02:29 pm
Kimia Biosciences Board Meeting on Nov 13 to Approve Q2 Results
AI Summary
Kimia Biosciences Ltd has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the Un-Audited Financial Results (Standalone) for the second quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for designated persons has been closed from October 1, 2026, until 48 hours after the results are declared.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve un-audited financial results for Q2 and H1 FY27.
- Trading window closed for designated persons.
- Results pertain to the period ending September 30, 2026.
Price Impact
More from KIMIABL